nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—Barrett's esophagus	0.181	1	CbGaD
Celecoxib—kidney cancer—Esomeprazole—Barrett's esophagus	0.129	0.227	CpDpCtD
Celecoxib—kidney cancer—Omeprazole—Barrett's esophagus	0.129	0.227	CpDpCtD
Celecoxib—prostate cancer—Omeprazole—Barrett's esophagus	0.0934	0.164	CpDpCtD
Celecoxib—prostate cancer—Esomeprazole—Barrett's esophagus	0.0934	0.164	CpDpCtD
Celecoxib—systemic scleroderma—Esomeprazole—Barrett's esophagus	0.0621	0.109	CpDpCtD
Celecoxib—systemic scleroderma—Omeprazole—Barrett's esophagus	0.0621	0.109	CpDpCtD
Celecoxib—CYP2C9—Omeprazole—Barrett's esophagus	0.0278	0.287	CbGbCtD
Celecoxib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0274	0.283	CbGbCtD
Celecoxib—CYP2D6—Omeprazole—Barrett's esophagus	0.0254	0.263	CbGbCtD
Celecoxib—CYP3A4—Omeprazole—Barrett's esophagus	0.0161	0.167	CbGbCtD
Celecoxib—ORM1—bile—Barrett's esophagus	0.00577	0.255	CbGeAlD
Celecoxib—CA6—exocrine gland—Barrett's esophagus	0.00358	0.158	CbGeAlD
Celecoxib—PDPK1—digestive system—Barrett's esophagus	0.00196	0.0867	CbGeAlD
Celecoxib—MAPK14—epithelium—Barrett's esophagus	0.00138	0.0609	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—Barrett's esophagus	0.00133	0.0587	CbGeAlD
Celecoxib—CA2—exocrine gland—Barrett's esophagus	0.00123	0.0545	CbGeAlD
Celecoxib—CA9—digestive system—Barrett's esophagus	0.00107	0.0475	CbGeAlD
Celecoxib—MAPK14—digestive system—Barrett's esophagus	0.00105	0.0463	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—Barrett's esophagus	0.000983	1	CrCbGaD
Celecoxib—CA12—digestive system—Barrett's esophagus	0.000794	0.0352	CbGeAlD
Celecoxib—CA2—epithelium—Barrett's esophagus	0.000536	0.0237	CbGeAlD
Celecoxib—ABCC4—digestive system—Barrett's esophagus	0.000535	0.0237	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—Barrett's esophagus	0.000516	0.0229	CbGeAlD
Celecoxib—CA4—digestive system—Barrett's esophagus	0.000492	0.0218	CbGeAlD
Celecoxib—CA2—digestive system—Barrett's esophagus	0.000408	0.0181	CbGeAlD
Celecoxib—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.000407	0.00386	CcSEcCtD
Celecoxib—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.000407	0.00386	CcSEcCtD
Celecoxib—Neoplasm—Omeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—Bladder pain—Omeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—Neoplasm—Esomeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—Bladder pain—Esomeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.000404	0.00384	CcSEcCtD
Celecoxib—PTGS2—epithelium—Barrett's esophagus	0.000396	0.0175	CbGeAlD
Celecoxib—Hypertonia—Omeprazole—Barrett's esophagus	0.000392	0.00372	CcSEcCtD
Celecoxib—Hypertonia—Esomeprazole—Barrett's esophagus	0.000392	0.00372	CcSEcCtD
Celecoxib—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000381	0.0169	CbGeAlD
Celecoxib—Ear pain—Omeprazole—Barrett's esophagus	0.000381	0.00361	CcSEcCtD
Celecoxib—Ear pain—Esomeprazole—Barrett's esophagus	0.000381	0.00361	CcSEcCtD
Celecoxib—Sleep disorder—Esomeprazole—Barrett's esophagus	0.000375	0.00356	CcSEcCtD
Celecoxib—Sleep disorder—Omeprazole—Barrett's esophagus	0.000375	0.00356	CcSEcCtD
Celecoxib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.000373	0.00355	CcSEcCtD
Celecoxib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.000373	0.00355	CcSEcCtD
Celecoxib—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.000371	0.00353	CcSEcCtD
Celecoxib—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.000371	0.00353	CcSEcCtD
Celecoxib—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00037	0.00351	CcSEcCtD
Celecoxib—Photosensitivity—Omeprazole—Barrett's esophagus	0.00037	0.00351	CcSEcCtD
Celecoxib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.000366	0.00348	CcSEcCtD
Celecoxib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.000366	0.00348	CcSEcCtD
Celecoxib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000361	0.00343	CcSEcCtD
Celecoxib—Hepatic failure—Omeprazole—Barrett's esophagus	0.000361	0.00343	CcSEcCtD
Celecoxib—Hot flush—Omeprazole—Barrett's esophagus	0.000347	0.0033	CcSEcCtD
Celecoxib—Hot flush—Esomeprazole—Barrett's esophagus	0.000347	0.0033	CcSEcCtD
Celecoxib—Increased appetite—Omeprazole—Barrett's esophagus	0.000346	0.00328	CcSEcCtD
Celecoxib—Increased appetite—Esomeprazole—Barrett's esophagus	0.000346	0.00328	CcSEcCtD
Celecoxib—CYP2C9—digestive system—Barrett's esophagus	0.000345	0.0153	CbGeAlD
Celecoxib—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.000344	0.00327	CcSEcCtD
Celecoxib—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.000344	0.00327	CcSEcCtD
Celecoxib—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.000333	0.00316	CcSEcCtD
Celecoxib—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.000333	0.00316	CcSEcCtD
Celecoxib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000326	0.0031	CcSEcCtD
Celecoxib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000326	0.0031	CcSEcCtD
Celecoxib—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000325	0.00308	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000325	0.00308	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000325	0.00308	CcSEcCtD
Celecoxib—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000325	0.00308	CcSEcCtD
Celecoxib—Migraine—Esomeprazole—Barrett's esophagus	0.00032	0.00304	CcSEcCtD
Celecoxib—Migraine—Omeprazole—Barrett's esophagus	0.00032	0.00304	CcSEcCtD
Celecoxib—Face oedema—Omeprazole—Barrett's esophagus	0.000313	0.00298	CcSEcCtD
Celecoxib—Face oedema—Esomeprazole—Barrett's esophagus	0.000313	0.00298	CcSEcCtD
Celecoxib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000304	0.00289	CcSEcCtD
Celecoxib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000304	0.00289	CcSEcCtD
Celecoxib—PTGS2—digestive system—Barrett's esophagus	0.000301	0.0133	CbGeAlD
Celecoxib—Dry skin—Omeprazole—Barrett's esophagus	0.000298	0.00283	CcSEcCtD
Celecoxib—Dry skin—Esomeprazole—Barrett's esophagus	0.000298	0.00283	CcSEcCtD
Celecoxib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000297	0.00282	CcSEcCtD
Celecoxib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000297	0.00282	CcSEcCtD
Celecoxib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000295	0.00281	CcSEcCtD
Celecoxib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000295	0.00281	CcSEcCtD
Celecoxib—Breast disorder—Esomeprazole—Barrett's esophagus	0.000293	0.00279	CcSEcCtD
Celecoxib—Breast disorder—Omeprazole—Barrett's esophagus	0.000293	0.00279	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000292	0.00278	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000292	0.00278	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000292	0.00278	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000292	0.00278	CcSEcCtD
Celecoxib—Gastritis—Esomeprazole—Barrett's esophagus	0.000287	0.00273	CcSEcCtD
Celecoxib—Gastritis—Omeprazole—Barrett's esophagus	0.000287	0.00273	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000286	0.00272	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000286	0.00272	CcSEcCtD
Celecoxib—Dysphagia—Esomeprazole—Barrett's esophagus	0.000281	0.00267	CcSEcCtD
Celecoxib—Dysphagia—Omeprazole—Barrett's esophagus	0.000281	0.00267	CcSEcCtD
Celecoxib—Bronchospasm—Omeprazole—Barrett's esophagus	0.000276	0.00262	CcSEcCtD
Celecoxib—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000276	0.00262	CcSEcCtD
Celecoxib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000275	0.00261	CcSEcCtD
Celecoxib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000275	0.00261	CcSEcCtD
Celecoxib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000273	0.0026	CcSEcCtD
Celecoxib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000273	0.0026	CcSEcCtD
Celecoxib—Sweating increased—Omeprazole—Barrett's esophagus	0.000273	0.0026	CcSEcCtD
Celecoxib—Sweating increased—Esomeprazole—Barrett's esophagus	0.000273	0.0026	CcSEcCtD
Celecoxib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000266	0.00253	CcSEcCtD
Celecoxib—Pancytopenia—Omeprazole—Barrett's esophagus	0.000266	0.00253	CcSEcCtD
Celecoxib—CYP3A4—digestive system—Barrett's esophagus	0.000263	0.0116	CbGeAlD
Celecoxib—Dysuria—Esomeprazole—Barrett's esophagus	0.000262	0.00249	CcSEcCtD
Celecoxib—Dysuria—Omeprazole—Barrett's esophagus	0.000262	0.00249	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000261	0.00248	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000261	0.00248	CcSEcCtD
Celecoxib—Pollakiuria—Omeprazole—Barrett's esophagus	0.000259	0.00246	CcSEcCtD
Celecoxib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000259	0.00246	CcSEcCtD
Celecoxib—CYP2D6—digestive system—Barrett's esophagus	0.000259	0.0115	CbGeAlD
Celecoxib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000256	0.00243	CcSEcCtD
Celecoxib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000256	0.00243	CcSEcCtD
Celecoxib—Weight increased—Omeprazole—Barrett's esophagus	0.000255	0.00243	CcSEcCtD
Celecoxib—Weight increased—Esomeprazole—Barrett's esophagus	0.000255	0.00243	CcSEcCtD
Celecoxib—Infestation—Omeprazole—Barrett's esophagus	0.00025	0.00238	CcSEcCtD
Celecoxib—Infestation—Esomeprazole—Barrett's esophagus	0.00025	0.00238	CcSEcCtD
Celecoxib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00025	0.00238	CcSEcCtD
Celecoxib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00025	0.00238	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000248	0.00236	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000248	0.00236	CcSEcCtD
Celecoxib—Stomatitis—Omeprazole—Barrett's esophagus	0.000244	0.00232	CcSEcCtD
Celecoxib—Jaundice—Omeprazole—Barrett's esophagus	0.000244	0.00232	CcSEcCtD
Celecoxib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000244	0.00232	CcSEcCtD
Celecoxib—Jaundice—Esomeprazole—Barrett's esophagus	0.000244	0.00232	CcSEcCtD
Celecoxib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000243	0.00231	CcSEcCtD
Celecoxib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000243	0.00231	CcSEcCtD
Celecoxib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000243	0.00231	CcSEcCtD
Celecoxib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000243	0.00231	CcSEcCtD
Celecoxib—Haematuria—Esomeprazole—Barrett's esophagus	0.000239	0.00227	CcSEcCtD
Celecoxib—Haematuria—Omeprazole—Barrett's esophagus	0.000239	0.00227	CcSEcCtD
Celecoxib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000237	0.00225	CcSEcCtD
Celecoxib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000237	0.00225	CcSEcCtD
Celecoxib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000236	0.00224	CcSEcCtD
Celecoxib—Epistaxis—Omeprazole—Barrett's esophagus	0.000236	0.00224	CcSEcCtD
Celecoxib—Sinusitis—Esomeprazole—Barrett's esophagus	0.000235	0.00223	CcSEcCtD
Celecoxib—Sinusitis—Omeprazole—Barrett's esophagus	0.000235	0.00223	CcSEcCtD
Celecoxib—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000233	0.00222	CcSEcCtD
Celecoxib—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000233	0.00222	CcSEcCtD
Celecoxib—Rhinitis—Omeprazole—Barrett's esophagus	0.000225	0.00214	CcSEcCtD
Celecoxib—Rhinitis—Esomeprazole—Barrett's esophagus	0.000225	0.00214	CcSEcCtD
Celecoxib—Hepatitis—Omeprazole—Barrett's esophagus	0.000225	0.00213	CcSEcCtD
Celecoxib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000225	0.00213	CcSEcCtD
Celecoxib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Hallucination—Esomeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Hallucination—Omeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Pharyngitis—Omeprazole—Barrett's esophagus	0.000223	0.00212	CcSEcCtD
Celecoxib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000222	0.00211	CcSEcCtD
Celecoxib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000222	0.00211	CcSEcCtD
Celecoxib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000221	0.0021	CcSEcCtD
Celecoxib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000221	0.0021	CcSEcCtD
Celecoxib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000221	0.0021	CcSEcCtD
Celecoxib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000221	0.0021	CcSEcCtD
Celecoxib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00022	0.00209	CcSEcCtD
Celecoxib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00022	0.00209	CcSEcCtD
Celecoxib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000212	0.00202	CcSEcCtD
Celecoxib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000212	0.00202	CcSEcCtD
Celecoxib—Eye disorder—Omeprazole—Barrett's esophagus	0.00021	0.00199	CcSEcCtD
Celecoxib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00021	0.00199	CcSEcCtD
Celecoxib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000209	0.00199	CcSEcCtD
Celecoxib—Tinnitus—Omeprazole—Barrett's esophagus	0.000209	0.00199	CcSEcCtD
Celecoxib—Flushing—Esomeprazole—Barrett's esophagus	0.000208	0.00198	CcSEcCtD
Celecoxib—Flushing—Omeprazole—Barrett's esophagus	0.000208	0.00198	CcSEcCtD
Celecoxib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000203	0.00193	CcSEcCtD
Celecoxib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000203	0.00193	CcSEcCtD
Celecoxib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000202	0.00192	CcSEcCtD
Celecoxib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000202	0.00192	CcSEcCtD
Celecoxib—Alopecia—Esomeprazole—Barrett's esophagus	0.000198	0.00189	CcSEcCtD
Celecoxib—Alopecia—Omeprazole—Barrett's esophagus	0.000198	0.00189	CcSEcCtD
Celecoxib—Mental disorder—Omeprazole—Barrett's esophagus	0.000197	0.00187	CcSEcCtD
Celecoxib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000197	0.00187	CcSEcCtD
Celecoxib—Flatulence—Omeprazole—Barrett's esophagus	0.000193	0.00183	CcSEcCtD
Celecoxib—Flatulence—Esomeprazole—Barrett's esophagus	0.000193	0.00183	CcSEcCtD
Celecoxib—Tension—Esomeprazole—Barrett's esophagus	0.000192	0.00182	CcSEcCtD
Celecoxib—Tension—Omeprazole—Barrett's esophagus	0.000192	0.00182	CcSEcCtD
Celecoxib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000191	0.00182	CcSEcCtD
Celecoxib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000191	0.00182	CcSEcCtD
Celecoxib—Nervousness—Esomeprazole—Barrett's esophagus	0.00019	0.0018	CcSEcCtD
Celecoxib—Nervousness—Omeprazole—Barrett's esophagus	0.00019	0.0018	CcSEcCtD
Celecoxib—Back pain—Omeprazole—Barrett's esophagus	0.000189	0.0018	CcSEcCtD
Celecoxib—Back pain—Esomeprazole—Barrett's esophagus	0.000189	0.0018	CcSEcCtD
Celecoxib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000188	0.00179	CcSEcCtD
Celecoxib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000188	0.00179	CcSEcCtD
Celecoxib—Vision blurred—Omeprazole—Barrett's esophagus	0.000184	0.00175	CcSEcCtD
Celecoxib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000184	0.00175	CcSEcCtD
Celecoxib—Anaemia—Omeprazole—Barrett's esophagus	0.000181	0.00172	CcSEcCtD
Celecoxib—Anaemia—Esomeprazole—Barrett's esophagus	0.000181	0.00172	CcSEcCtD
Celecoxib—Angioedema—Esomeprazole—Barrett's esophagus	0.000179	0.0017	CcSEcCtD
Celecoxib—Angioedema—Omeprazole—Barrett's esophagus	0.000179	0.0017	CcSEcCtD
Celecoxib—Vertigo—Esomeprazole—Barrett's esophagus	0.000176	0.00167	CcSEcCtD
Celecoxib—Vertigo—Omeprazole—Barrett's esophagus	0.000176	0.00167	CcSEcCtD
Celecoxib—Leukopenia—Esomeprazole—Barrett's esophagus	0.000175	0.00166	CcSEcCtD
Celecoxib—Leukopenia—Omeprazole—Barrett's esophagus	0.000175	0.00166	CcSEcCtD
Celecoxib—Palpitations—Omeprazole—Barrett's esophagus	0.000173	0.00164	CcSEcCtD
Celecoxib—Palpitations—Esomeprazole—Barrett's esophagus	0.000173	0.00164	CcSEcCtD
Celecoxib—Cough—Omeprazole—Barrett's esophagus	0.000171	0.00162	CcSEcCtD
Celecoxib—Cough—Esomeprazole—Barrett's esophagus	0.000171	0.00162	CcSEcCtD
Celecoxib—Hypertension—Omeprazole—Barrett's esophagus	0.000169	0.0016	CcSEcCtD
Celecoxib—Hypertension—Esomeprazole—Barrett's esophagus	0.000169	0.0016	CcSEcCtD
Celecoxib—Chest pain—Omeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Arthralgia—Omeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Myalgia—Omeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Myalgia—Esomeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Chest pain—Esomeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Anxiety—Esomeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Anxiety—Omeprazole—Barrett's esophagus	0.000166	0.00158	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000165	0.00157	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000165	0.00157	CcSEcCtD
Celecoxib—Dry mouth—Omeprazole—Barrett's esophagus	0.000163	0.00155	CcSEcCtD
Celecoxib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000163	0.00155	CcSEcCtD
Celecoxib—Confusional state—Esomeprazole—Barrett's esophagus	0.000161	0.00153	CcSEcCtD
Celecoxib—Confusional state—Omeprazole—Barrett's esophagus	0.000161	0.00153	CcSEcCtD
Celecoxib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00016	0.00152	CcSEcCtD
Celecoxib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00016	0.00152	CcSEcCtD
Celecoxib—Infection—Omeprazole—Barrett's esophagus	0.000159	0.00151	CcSEcCtD
Celecoxib—Infection—Esomeprazole—Barrett's esophagus	0.000159	0.00151	CcSEcCtD
Celecoxib—Shock—Esomeprazole—Barrett's esophagus	0.000157	0.00149	CcSEcCtD
Celecoxib—Shock—Omeprazole—Barrett's esophagus	0.000157	0.00149	CcSEcCtD
Celecoxib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000156	0.00149	CcSEcCtD
Celecoxib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000156	0.00149	CcSEcCtD
Celecoxib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000156	0.00148	CcSEcCtD
Celecoxib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000156	0.00148	CcSEcCtD
Celecoxib—Tachycardia—Esomeprazole—Barrett's esophagus	0.000156	0.00148	CcSEcCtD
Celecoxib—Tachycardia—Omeprazole—Barrett's esophagus	0.000156	0.00148	CcSEcCtD
Celecoxib—Skin disorder—Omeprazole—Barrett's esophagus	0.000155	0.00147	CcSEcCtD
Celecoxib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000155	0.00147	CcSEcCtD
Celecoxib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000154	0.00147	CcSEcCtD
Celecoxib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000154	0.00147	CcSEcCtD
Celecoxib—Anorexia—Esomeprazole—Barrett's esophagus	0.000152	0.00144	CcSEcCtD
Celecoxib—Anorexia—Omeprazole—Barrett's esophagus	0.000152	0.00144	CcSEcCtD
Celecoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00015	0.00632	CbGpPWpGaD
Celecoxib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000146	0.00613	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000145	0.00138	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000145	0.00138	CcSEcCtD
Celecoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000145	0.00608	CbGpPWpGaD
Celecoxib—Insomnia—Omeprazole—Barrett's esophagus	0.000144	0.00137	CcSEcCtD
Celecoxib—Insomnia—Esomeprazole—Barrett's esophagus	0.000144	0.00137	CcSEcCtD
Celecoxib—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000144	0.00605	CbGpPWpGaD
Celecoxib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000143	0.00136	CcSEcCtD
Celecoxib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000143	0.00136	CcSEcCtD
Celecoxib—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000143	0.006	CbGpPWpGaD
Celecoxib—ABCC4—Platelet degranulation—HGF—Barrett's esophagus	0.000142	0.00599	CbGpPWpGaD
Celecoxib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000142	0.00135	CcSEcCtD
Celecoxib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000142	0.00135	CcSEcCtD
Celecoxib—Somnolence—Esomeprazole—Barrett's esophagus	0.000142	0.00135	CcSEcCtD
Celecoxib—Somnolence—Omeprazole—Barrett's esophagus	0.000142	0.00135	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000142	0.00596	CbGpPWpGaD
Celecoxib—Dyspepsia—Omeprazole—Barrett's esophagus	0.00014	0.00133	CcSEcCtD
Celecoxib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00014	0.00133	CcSEcCtD
Celecoxib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000139	0.00132	CcSEcCtD
Celecoxib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000139	0.00132	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000138	0.00131	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000138	0.00131	CcSEcCtD
Celecoxib—Fatigue—Omeprazole—Barrett's esophagus	0.000138	0.00131	CcSEcCtD
Celecoxib—Fatigue—Esomeprazole—Barrett's esophagus	0.000138	0.00131	CcSEcCtD
Celecoxib—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000137	0.00578	CbGpPWpGaD
Celecoxib—MAPK14—CD40/CD40L signaling—RELA—Barrett's esophagus	0.000137	0.00576	CbGpPWpGaD
Celecoxib—Constipation—Omeprazole—Barrett's esophagus	0.000136	0.0013	CcSEcCtD
Celecoxib—Constipation—Esomeprazole—Barrett's esophagus	0.000136	0.0013	CcSEcCtD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.000136	0.00573	CbGpPWpGaD
Celecoxib—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000136	0.0057	CbGpPWpGaD
Celecoxib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000131	0.00125	CcSEcCtD
Celecoxib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000131	0.00125	CcSEcCtD
Celecoxib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00013	0.00124	CcSEcCtD
Celecoxib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00013	0.00124	CcSEcCtD
Celecoxib—Urticaria—Omeprazole—Barrett's esophagus	0.000127	0.0012	CcSEcCtD
Celecoxib—Urticaria—Esomeprazole—Barrett's esophagus	0.000127	0.0012	CcSEcCtD
Celecoxib—PDPK1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000127	0.00533	CbGpPWpGaD
Celecoxib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000126	0.0012	CcSEcCtD
Celecoxib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000126	0.0012	CcSEcCtD
Celecoxib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000126	0.0012	CcSEcCtD
Celecoxib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000126	0.0012	CcSEcCtD
Celecoxib—MAPK14—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000121	0.00509	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—HGF—Barrett's esophagus	0.00012	0.00505	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000119	0.00502	CbGpPWpGaD
Celecoxib—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000118	0.00497	CbGpPWpGaD
Celecoxib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000118	0.00112	CcSEcCtD
Celecoxib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000118	0.00112	CcSEcCtD
Celecoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000117	0.00493	CbGpPWpGaD
Celecoxib—Asthenia—Omeprazole—Barrett's esophagus	0.000114	0.00109	CcSEcCtD
Celecoxib—Asthenia—Esomeprazole—Barrett's esophagus	0.000114	0.00109	CcSEcCtD
Celecoxib—Pruritus—Esomeprazole—Barrett's esophagus	0.000113	0.00107	CcSEcCtD
Celecoxib—Pruritus—Omeprazole—Barrett's esophagus	0.000113	0.00107	CcSEcCtD
Celecoxib—PDPK1—BDNF signaling pathway—APC—Barrett's esophagus	0.000111	0.00468	CbGpPWpGaD
Celecoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000111	0.00466	CbGpPWpGaD
Celecoxib—MAPK14—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000111	0.00466	CbGpPWpGaD
Celecoxib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000109	0.00104	CcSEcCtD
Celecoxib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000109	0.00104	CcSEcCtD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000106	0.00448	CbGpPWpGaD
Celecoxib—Dizziness—Omeprazole—Barrett's esophagus	0.000106	0.001	CcSEcCtD
Celecoxib—Dizziness—Esomeprazole—Barrett's esophagus	0.000106	0.001	CcSEcCtD
Celecoxib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—Barrett's esophagus	0.000105	0.00443	CbGpPWpGaD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000105	0.00443	CbGpPWpGaD
Celecoxib—MAPK14—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000104	0.00439	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.000104	0.00438	CbGpPWpGaD
Celecoxib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000104	0.00438	CbGpPWpGaD
Celecoxib—MAPK14—CDC42 signaling events—APC—Barrett's esophagus	0.000103	0.00433	CbGpPWpGaD
Celecoxib—Vomiting—Esomeprazole—Barrett's esophagus	0.000101	0.000964	CcSEcCtD
Celecoxib—Vomiting—Omeprazole—Barrett's esophagus	0.000101	0.000964	CcSEcCtD
Celecoxib—CA14—Metabolism—PTGES—Barrett's esophagus	0.000101	0.00426	CbGpPWpGaD
Celecoxib—Rash—Omeprazole—Barrett's esophagus	0.000101	0.000956	CcSEcCtD
Celecoxib—Rash—Esomeprazole—Barrett's esophagus	0.000101	0.000956	CcSEcCtD
Celecoxib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000101	0.000955	CcSEcCtD
Celecoxib—Dermatitis—Omeprazole—Barrett's esophagus	0.000101	0.000955	CcSEcCtD
Celecoxib—Headache—Esomeprazole—Barrett's esophagus	0.0001	0.000949	CcSEcCtD
Celecoxib—Headache—Omeprazole—Barrett's esophagus	0.0001	0.000949	CcSEcCtD
Celecoxib—MAPK14—IL-4 Signaling Pathway—RELA—Barrett's esophagus	9.9e-05	0.00417	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGES—Barrett's esophagus	9.87e-05	0.00415	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGES—Barrett's esophagus	9.87e-05	0.00415	CbGpPWpGaD
Celecoxib—MAPK14—IL-1 signaling pathway—RELA—Barrett's esophagus	9.76e-05	0.00411	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	9.76e-05	0.00411	CbGpPWpGaD
Celecoxib—ABCC4—Fluoropyrimidine Activity—TP53—Barrett's esophagus	9.7e-05	0.00408	CbGpPWpGaD
Celecoxib—MAPK14—p53 pathway—CDKN2A—Barrett's esophagus	9.58e-05	0.00403	CbGpPWpGaD
Celecoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	9.53e-05	0.00401	CbGpPWpGaD
Celecoxib—Nausea—Esomeprazole—Barrett's esophagus	9.48e-05	0.0009	CcSEcCtD
Celecoxib—Nausea—Omeprazole—Barrett's esophagus	9.48e-05	0.0009	CcSEcCtD
Celecoxib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	9.41e-05	0.00396	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGES—Barrett's esophagus	9.22e-05	0.00388	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—RELA—Barrett's esophagus	9.1e-05	0.00383	CbGpPWpGaD
Celecoxib—ABCC4—NRF2 pathway—HGF—Barrett's esophagus	8.8e-05	0.0037	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	8.76e-05	0.00369	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—RELA—Barrett's esophagus	8.69e-05	0.00366	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	8.69e-05	0.00366	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGES—Barrett's esophagus	8.54e-05	0.00359	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	8.54e-05	0.00359	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—RELA—Barrett's esophagus	8.43e-05	0.00355	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	8.33e-05	0.00351	CbGpPWpGaD
Celecoxib—MAPK14—BCR signaling pathway—RELA—Barrett's esophagus	8.33e-05	0.00351	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	8.31e-05	0.0035	CbGpPWpGaD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	8.1e-05	0.00341	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	7.89e-05	0.00332	CbGpPWpGaD
Celecoxib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	7.73e-05	0.00325	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	7.72e-05	0.00325	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CYP26A1—Barrett's esophagus	7.68e-05	0.00323	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	7.61e-05	0.0032	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—RELA—Barrett's esophagus	7.61e-05	0.0032	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	7.58e-05	0.00319	CbGpPWpGaD
Celecoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	7.49e-05	0.00315	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CYP26A1—Barrett's esophagus	7.48e-05	0.00315	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CYP26A1—Barrett's esophagus	7.48e-05	0.00315	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	7.37e-05	0.0031	CbGpPWpGaD
Celecoxib—MAPK14—p73 transcription factor network—RELA—Barrett's esophagus	7.3e-05	0.00307	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.21e-05	0.00304	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	7.19e-05	0.00303	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—GAST—Barrett's esophagus	7.09e-05	0.00299	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	7.09e-05	0.00298	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CYP26A1—Barrett's esophagus	6.98e-05	0.00294	CbGpPWpGaD
Celecoxib—MAPK14—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	6.89e-05	0.0029	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	6.82e-05	0.00287	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—RELA—Barrett's esophagus	6.82e-05	0.00287	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGES—Barrett's esophagus	6.81e-05	0.00286	CbGpPWpGaD
Celecoxib—MAPK14—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	6.7e-05	0.00282	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	6.68e-05	0.00281	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—RELA—Barrett's esophagus	6.58e-05	0.00277	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGES—Barrett's esophagus	6.53e-05	0.00275	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CYP26A1—Barrett's esophagus	6.47e-05	0.00272	CbGpPWpGaD
Celecoxib—MAPK14—Corticotropin-releasing hormone—RELA—Barrett's esophagus	6.46e-05	0.00272	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	6.46e-05	0.00272	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—GAST—Barrett's esophagus	6.44e-05	0.00271	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—HGF—Barrett's esophagus	6.44e-05	0.00271	CbGpPWpGaD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	6.35e-05	0.00267	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	6.34e-05	0.00267	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	6.31e-05	0.00266	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	6.28e-05	0.00264	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	6.22e-05	0.00262	CbGpPWpGaD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	6.2e-05	0.00261	CbGpPWpGaD
Celecoxib—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.19e-05	0.00261	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.14e-05	0.00258	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	6.13e-05	0.00258	CbGpPWpGaD
Celecoxib—MAPK14—MyD88-independent cascade—RELA—Barrett's esophagus	6.1e-05	0.00257	CbGpPWpGaD
Celecoxib—MAPK14—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	6.09e-05	0.00256	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	6.04e-05	0.00254	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	5.95e-05	0.0025	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—APC—Barrett's esophagus	5.78e-05	0.00243	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	5.61e-05	0.00236	CbGpPWpGaD
Celecoxib—CA14—Metabolism—SLC9A1—Barrett's esophagus	5.53e-05	0.00233	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	5.53e-05	0.00233	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGES—Barrett's esophagus	5.5e-05	0.00231	CbGpPWpGaD
Celecoxib—MAPK14—Activated TLR4 signalling—RELA—Barrett's esophagus	5.48e-05	0.00231	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HGF—Barrett's esophagus	5.48e-05	0.00231	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	5.48e-05	0.00231	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—CDKN2A—Barrett's esophagus	5.47e-05	0.0023	CbGpPWpGaD
Celecoxib—CA6—Metabolism—SLC9A1—Barrett's esophagus	5.39e-05	0.00227	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—SLC9A1—Barrett's esophagus	5.39e-05	0.00227	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	5.36e-05	0.00225	CbGpPWpGaD
Celecoxib—MAPK14—p53 pathway—TP53—Barrett's esophagus	5.33e-05	0.00224	CbGpPWpGaD
Celecoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	5.17e-05	0.00218	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CYP26A1—Barrett's esophagus	5.16e-05	0.00217	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	5.16e-05	0.00217	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—SLC9A1—Barrett's esophagus	5.03e-05	0.00212	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—RELA—Barrett's esophagus	5.02e-05	0.00211	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CYP26A1—Barrett's esophagus	4.95e-05	0.00208	CbGpPWpGaD
Celecoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	4.94e-05	0.00208	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	4.94e-05	0.00208	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—SST—Barrett's esophagus	4.86e-05	0.00205	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	4.82e-05	0.00203	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—CDKN2A—Barrett's esophagus	4.79e-05	0.00202	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.76e-05	0.002	CbGpPWpGaD
Celecoxib—CA12—Metabolism—SLC9A1—Barrett's esophagus	4.66e-05	0.00196	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	4.65e-05	0.00196	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	4.62e-05	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.61e-05	0.00194	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—RELA—Barrett's esophagus	4.61e-05	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	4.59e-05	0.00193	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—RELA—Barrett's esophagus	4.52e-05	0.0019	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.42e-05	0.00186	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—SST—Barrett's esophagus	4.42e-05	0.00186	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	4.38e-05	0.00184	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—RELA—Barrett's esophagus	4.36e-05	0.00183	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—CXCL8—Barrett's esophagus	4.34e-05	0.00183	CbGpPWpGaD
Celecoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	4.33e-05	0.00182	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	4.28e-05	0.0018	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CYP26A1—Barrett's esophagus	4.17e-05	0.00175	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SLC9A1—Barrett's esophagus	4.17e-05	0.00175	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	4.1e-05	0.00173	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	4.1e-05	0.00172	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.05e-05	0.0017	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	3.94e-05	0.00166	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.85e-05	0.00162	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—CDKN2A—Barrett's esophagus	3.82e-05	0.00161	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GAST—Barrett's esophagus	3.81e-05	0.0016	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SLC9A1—Barrett's esophagus	3.72e-05	0.00156	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—RELA—Barrett's esophagus	3.68e-05	0.00155	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC9A1—Barrett's esophagus	3.57e-05	0.0015	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.5e-05	0.00147	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—CXCL8—Barrett's esophagus	3.47e-05	0.00146	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	3.46e-05	0.00146	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	3.36e-05	0.00142	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	3.36e-05	0.00142	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	3.26e-05	0.00137	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HGF—Barrett's esophagus	3.25e-05	0.00137	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR1I2—Barrett's esophagus	3.24e-05	0.00136	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	3.19e-05	0.00134	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.15e-05	0.00133	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—Barrett's esophagus	3.04e-05	0.00128	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC9A1—Barrett's esophagus	3.01e-05	0.00126	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	2.95e-05	0.00124	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN2A—Barrett's esophagus	2.89e-05	0.00122	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HGF—Barrett's esophagus	2.87e-05	0.00121	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—RELA—Barrett's esophagus	2.86e-05	0.0012	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	2.86e-05	0.0012	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HGF—Barrett's esophagus	2.85e-05	0.0012	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	2.8e-05	0.00118	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—RELA—Barrett's esophagus	2.78e-05	0.00117	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—RELA—Barrett's esophagus	2.75e-05	0.00116	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—Barrett's esophagus	2.67e-05	0.00112	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CXCL8—Barrett's esophagus	2.62e-05	0.0011	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—RELA—Barrett's esophagus	2.61e-05	0.0011	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SST—Barrett's esophagus	2.61e-05	0.0011	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PPARG—Barrett's esophagus	2.53e-05	0.00106	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—Barrett's esophagus	2.52e-05	0.00106	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PPARG—Barrett's esophagus	2.46e-05	0.00104	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PPARG—Barrett's esophagus	2.46e-05	0.00104	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—Barrett's esophagus	2.31e-05	0.000972	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PPARG—Barrett's esophagus	2.3e-05	0.000967	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PPARG—Barrett's esophagus	2.13e-05	0.000896	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—Barrett's esophagus	2.13e-05	0.000896	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTGES—Barrett's esophagus	2.12e-05	0.000892	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.08e-05	0.000877	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PPARG—Barrett's esophagus	2.08e-05	0.000876	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	2e-05	0.000842	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—Barrett's esophagus	1.99e-05	0.000836	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GAST—Barrett's esophagus	1.98e-05	0.000832	CbGpPWpGaD
Celecoxib—PDPK1—Disease—APC—Barrett's esophagus	1.97e-05	0.000829	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	1.96e-05	0.000824	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—Barrett's esophagus	1.94e-05	0.000815	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—Barrett's esophagus	1.94e-05	0.000815	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.89e-05	0.000797	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—Barrett's esophagus	1.84e-05	0.000774	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—Barrett's esophagus	1.81e-05	0.000761	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.72e-05	0.000724	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGES—Barrett's esophagus	1.72e-05	0.000722	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARG—Barrett's esophagus	1.7e-05	0.000714	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—RELA—Barrett's esophagus	1.68e-05	0.000709	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—Barrett's esophagus	1.67e-05	0.000705	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—RELA—Barrett's esophagus	1.67e-05	0.000702	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARG—Barrett's esophagus	1.63e-05	0.000685	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—Barrett's esophagus	1.61e-05	0.000677	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	1.61e-05	0.000676	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—Barrett's esophagus	1.5e-05	0.00063	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HGF—Barrett's esophagus	1.49e-05	0.000629	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RELA—Barrett's esophagus	1.49e-05	0.000626	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HGF—Barrett's esophagus	1.47e-05	0.00062	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	1.42e-05	0.000596	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	1.4e-05	0.000591	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC9A1—Barrett's esophagus	1.38e-05	0.000582	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—APC—Barrett's esophagus	1.38e-05	0.000581	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARG—Barrett's esophagus	1.37e-05	0.000577	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SST—Barrett's esophagus	1.36e-05	0.00057	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—Barrett's esophagus	1.34e-05	0.000562	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.33e-05	0.00056	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP26A1—Barrett's esophagus	1.3e-05	0.000547	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—Barrett's esophagus	1.28e-05	0.000539	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.19e-05	0.0005	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	1.16e-05	0.000487	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—Barrett's esophagus	1.09e-05	0.000459	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—Barrett's esophagus	1.08e-05	0.000454	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RELA—Barrett's esophagus	1.08e-05	0.000454	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	1.07e-05	0.000452	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—Barrett's esophagus	1.06e-05	0.000448	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.06e-05	0.000448	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.02e-05	0.000428	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.61e-06	0.000404	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—Barrett's esophagus	9.56e-06	0.000402	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC9A1—Barrett's esophagus	9.37e-06	0.000394	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	9.26e-06	0.00039	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RELA—Barrett's esophagus	8.67e-06	0.000365	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.86e-06	0.000331	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	7.74e-06	0.000326	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	7.67e-06	0.000323	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.56e-06	0.000318	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APC—Barrett's esophagus	7.17e-06	0.000302	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	7.02e-06	0.000295	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APC—Barrett's esophagus	6.54e-06	0.000275	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—Barrett's esophagus	6.24e-06	0.000262	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	6.19e-06	0.00026	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—Barrett's esophagus	5.6e-06	0.000236	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—Barrett's esophagus	5.29e-06	0.000223	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—Barrett's esophagus	5.28e-06	0.000222	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	5.06e-06	0.000213	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—Barrett's esophagus	4.94e-06	0.000208	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—Barrett's esophagus	4.28e-06	0.00018	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	3.53e-06	0.000149	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	3.5e-06	0.000147	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—Barrett's esophagus	3.37e-06	0.000142	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—Barrett's esophagus	3.24e-06	0.000136	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.78e-06	0.000117	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	2.75e-06	0.000116	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.31e-06	9.72e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.82e-06	7.64e-05	CbGpPWpGaD
